Activated T cell therapy for advanced melanoma developed

7 julio 2015

T cells from patients with melanoma can trigger a protective immune response against the disease, according to a new study. These new findings demonstrate that T cells derived from lymph nodes of patients with melanoma can be expanded in number and activated in the laboratory for intravenous administration in the treatment of patients.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/lgxsihV1sjs/150707134206.htm

Volver